GS
GRCL

GTS Securities’s Gracell Biotechnologies Inc. American Depositary Shares GRCL Stock Holding History

GTS Securities’s Portfolio GRCL Stock Details GRCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-25,144
Closed -$252K – 2224
2023
Q4 		$252K Buy
+25,144
New +$252K ﹤0.01% 1220